Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients...
Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundInfliximab is an efficacious therapy for inflammatory bowel disease and may play a role in management of some extraintestinal manifestations. While higher trough levels of infliximab are associated with higher rates of disease remission, the association between trough levels of infliximab and arthralgia activity characterised as an extrai...
Alternative Titles
Full title
Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_abc336d113084fb2bcc5b2e38fe84c4c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abc336d113084fb2bcc5b2e38fe84c4c
Other Identifiers
ISSN
2054-4774
E-ISSN
2054-4774
DOI
10.1136/bmjgast-2021-000788
